Dan P Zandberg (Dan Zandberg)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Prognostic Factors

Monoclonal Antibody

Top Venues

Cancer immunology, immunotherapy : CII

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

John F Hilton, Patrick A Ott, Aaron R Hansen, Zujun Li, Matthen Mathew, Cristina H Messina, Vimal Dave, Xiao Ji, Natalie O Karpinich, Steven Hirschfeld, Marc Ballas, Dan P Zandberg
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII 73 (3) (2024)
John F Hilton, Patrick A Ott, Aaron R Hansen, Zujun Li, Matthen Mathew, Cristina H Messina, Vimal Dave, Xiao Ji, Natalie O Karpinich, Steven Hirschfeld, Marc Ballas, Dan P Zandberg
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII 73 (3) (2024)
John F Hilton, Patrick A Ott, Aaron R Hansen, Zujun Li, Matthen Mathew, Cristina H Messina, Vimal Dave, Xiao Ji, Natalie O Karpinich, Steven Hirschfeld, Marc Ballas, Dan P Zandberg
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII 73 (3) (2024)
John F Hilton, Patrick A Ott, Aaron R Hansen, Zujun Li, Matthen Mathew, Cristina H Messina, Vimal Dave, Xiao Ji, Natalie O Karpinich, Steven Hirschfeld, Marc Ballas, Dan P Zandberg
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Dan P Zandberg, Serafettin Zenkin, Murat Ak, Priyadarshini Mamindla, Vishal Peddagangireddy, Ronan Hsieh, Jennifer L Anderson, Greg M Delgoffe, Ashely Menk, Heath D Skinner, Umamaheswar Duvvuri, Robert L Ferris, Rivka R Colen
Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients. Head & neck (2024)
Dan P Zandberg, Serafettin Zenkin, Murat Ak, Priyadarshini Mamindla, Vishal Peddagangireddy, Ronan Hsieh, Jennifer L Anderson, Greg M Delgoffe, Ashely Menk, Heath D Skinner, Umamaheswar Duvvuri, Robert L Ferris, Rivka R Colen
Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients. Head & neck (2024)
John F Hilton, Patrick A Ott, Aaron R Hansen, Zujun Li, Matthen Mathew, Cristina H Messina, Vimal Dave, Xiao Ji, Natalie O Karpinich, Steven Hirschfeld, Marc Ballas, Dan P Zandberg
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Rajiv Raja, Qu Zhang, Jiabu Ye, Philip He, Jagdish Shetty, Alejandro Yovine, Nicholas Holoweckyj, Katia Real, Jill Walker, Magdalena Wrona, Melissa de Los Reyes, Craig Barker, Jessica Whiteley, Robert I Haddad, Lisa F Licitra, Matthew J Ferris, Jérôme Fayette, Dan P Zandberg, Lillian L Siu, Ricard Mesía
Tumor Mutational Burden as a Predictor of Survival With Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Cecelia E Schmalbach, Thomas J Ow, Karen Y Choi, Miriam O'Leary, Alice Lin, Brian B Hughley, Kevin S Emerick, Brian Moore, Nancy Y Lee, Dan P Zandberg, Steven J Wang
American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma. Head & neck (2022)
Linwah Yip, William E Gooding, Alyaksandr Nikitski, Abigail I Wald, Sally E Carty, Esra Karslioglu-French, Raja R Seethala, Dan P Zandberg, Matthew J Ferris, Marina N Nikiforova, Yuri E Nikiforov
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study. Cancer 127 (11) (2021)
Harish Dharmarajan, Jennifer L Anderson, Seungwon Kim, Shaum Sridharan, Umamaheswar Duvvuri, Matthew J Ferris, Mario G Solari, David A Clump, Heath D Skinner, James P Ohr, Dan P Zandberg, Barton Branstetter, Marion A Hughes, Katie S Traylor, Raja Seethala, Simion I Chiosea, Marci L Nilsen, Jonas T Johnson, Mark W Kubik
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience. Head & neck 42 (6) (2020)
Marci Lee Nilsen, David A Clump, Mark W Kubik, Karen Losego, Alyssa Mrozek, Elizabeth Pawlowicz, Debra Pickford, Shaum Sridharan, Katie Traylor, Tamara Wasserman-Wincko, Kelly Young, Dan P Zandberg, Jonas T Johnson
Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic. Head & neck 42 (7) (2020)
Dan P Zandberg, Luke J Tallon, Sushma Nagaraj, Lisa K Sadzewicz, Yuji Zhang, Maxwell B Strome, Xuechu E Zhao, Kranthi Vavikolanu, Xiaoyu Zhang, John C Papadimitriou, Fleesie A Hubbard, Søren M Bentzen, Scott E Strome, Claire M Fraser
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity. Head & neck 41 (8) (2019)
Vinod Varki, Olga B Ioffe, Soren M Bentzen, Jon Heath, Ashley Cellini, Josephine Feliciano, Dan P Zandberg
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma. Cancer immunology, immunotherapy : CII 67 (5) (2018)